The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.

Existing research suggests scratching itchy skin can often make it worse, aggravating a wound and spreading harmful bacteria.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...

NICE has endorsed a new daily tablet treatment, Acarizax, designed to alleviate symptoms and enhance the quality of life for ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

The “life-changing” drug, Acarizax, works by delivering a fixed amount of house dust mite allergy extract every day to help ...

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...